The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Duhamel, M ^a   Rodet, F ^a   Murgoci, A N ^a   Desjardins, R ^b   Gagnon, H ^b   Wisztorski, M ^a   Fournier, I ^a   Day, R ^b   Salzet, M ^a  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CPG-OLIGONUCLEOTIDE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGODEOXYRIBONUCLEOTIDE; PROPROTEIN CONVERTASE 1; PROTEIN BINDING; STAT3 PROTEIN; TOLL LIKE RECEPTOR 9;

ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; ENDOSOME; ENZYME ACTIVATION; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG ALVEOLUS MACROPHAGE; METABOLISM; MOUSE; PERITONEUM MACROPHAGE; PROTEIN DEGRADATION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CYTOKINES; ENDOSOMES; ENZYME ACTIVATION; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; PROPROTEIN CONVERTASE 1; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEOLYSIS; RATS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 9;

EID: 84955143794     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19360     Document Type: Article

References (37)

1. Ostuni, R., Kratochvill, F., Murray, P. J., & Natoli, G. Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol 36, 229-239 (2015
2. Pohar, J., Kuznik Krajnik, A., Jerala, R., & Bencina, M. Minimal sequence requirements for oligodeoxyribonucleotides activating human TLR9. J Immunol 194, 3901-3908 (2015
3. Rodriguez, J. M., et al. PyNTTTTGT and CpG immunostimulatory oligonucleotides: effect on granulocyte/monocyte colonystimulating factor (GM-CSF) secretion by human CD56+ (NK and NKT) cells. PLoS One 10, e0117484 (2015
4. Kim, Y. H., et al. In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study. Blood 119, 355-363 (2012
5. Shirota, Y., Shirota, H., & Klinman, D. M. Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells. J Immunol 188, 1592-1599 (2012
6. Molenkamp, B. G., et al. Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients. Clin Cancer Res 14, 4532-4542 (2008
7. Brody, J. D., et al. In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study. J Clin Oncol 28, 4324-4332 (2010
8. Hofmann, M. A., et al. Phase 1 evaluation of intralesionally injected TLR9-Agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma. Journal of immunotherapy 31, 520-527 (2008
9. Chockalingam, A., Brooks, J. C., Cameron, J. L., Blum, L. K., & Leifer, C. A. TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA. Immunology and cell biology 87, 209-217 (2009
10. Latz, E., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 5, 190-198 (2004
11. Kim, Y. M., Brinkmann, M. M., Paquet, M. E., & Ploegh, H. L. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452, 234-238 (2008
12. Takahashi, K., et al. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. J Exp Med 204, 2963-2976 (2007
13. Demoulin, S., et al. HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells. Int J Cancer (2014
14. Brooks, J. C., Sun, W., Chiosis, G., & Leifer, C. A. Heat shock protein gp96 regulates Toll-like receptor 9 proteolytic processing and conformational stability. Biochem Biophys Res Commun 421, 780-784 (2012
15. Park, J. E., Kim, Y. I., & Yi, A. K. Protein kinase D1: a new component in TLR9 signaling. J Immunol 181, 2044-2055 (2008
16. Yoshizaki, M., et al. Spatiotemporal regulation of intracellular trafficking of Toll-like receptor 9 by an inhibitory receptor, Ly49Q. Blood 114, 1518-1527 (2009
17. Duhamel, M., et al. Molecular consequences of proprotein convertase 1/3 inhibition in macrophages for application to cancer immunotherapy: a proteomic study. Mol Cell Proteomics, doi: 10.1074/mcp.M115.052480 (2015
18. Refaie, S., et al. Disruption of proprotein convertase 1/3 (PC1/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion. J Biol Chem 287, 14703-14717 (2012
19. Gagnon, H., et al. Proprotein convertase 1/3 (PC1/3) in the rat alveolar macrophage cell line NR8383: localization, trafficking and effects on cytokine secretion. PLoS One 8, e61557 (2013
20. Moreira, D., et al. TLR9 signaling through NF-kappaB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells. Oncotarget 6, 17302-17313 (2015
21. Kortylewski, M., et al. Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy. Cancer Res 69, 2497-2505 (2009
22. St Germain, C., et al. Expression and transient nuclear translocation of proprotein convertase 1 (PC1) during mouse preimplantation embryonic development. Molecular reproduction and development 72, 483-493 (2005
23. Manoury, B. TLR9 regulation by proteolysis: a friend or a foe. Eur J Immunol 41, 2142-2144 (2011
24. Carpentier, A. F. [Cancer immunotherapy with CpG-ODN]. Med Sci (Paris) 21, 73-77 (2005
25. Ewald, S. E., & Barton, G. M. Nucleic acid sensing Toll-like receptors in autoimmunity. Current opinion in immunology 23, 3-9 (2011
26. Ewald, S. E., et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456, 658-662 (2008
27. Ewald, S. E., et al. Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J Exp Med 208, 643-651 (2011
28. Sepulveda, F. E., et al. Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 31, 737-748 (2009
29. Park, B., et al. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol 9, 1407-1414 (2008
30. Hipp, M. M., et al. Processing of human toll-like receptor 7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes. Immunity 39, 711-721 (2013
31. Kimura, T., et al. Endoplasmic Protein Nogo-B (RTN4-B) Interacts with GRAMD4 and Regulates TLR9-Mediated Innate Immune Responses. J Immunol 194, 5426-5436 (2015
32. Lee, B. L., et al. UNC93B1 mediates differential trafficking of endosomal TLRs. eLife 2, e00291 (2013
33. Chen, T. A., et al. Stimulation of Proliferation and Migration of Mouse Macrophages by Type B CpG-ODNs Is F-Spondin and IL-1Ra Dependent. PLoS One 10, e0128926 (2015
34. Ho, H. H., & Ivashkiv, L. B. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J Biol Chem 281, 14111-14118 (2006
35. Kortylewski, M., & Pal, S. K. The dark side of Toll-like receptor signaling: TLR9 activation limits the efficacy cancer radiotherapy. Oncoimmunology 3, e27894 (2014
36. Reynolds, E. S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17, 208-212 (1963
37. Griffiths, G., Simons, K., Warren, G., & Tokuyasu, K. T. Immunoelectron microscopy using thin, frozen sections: application to studies of the intracellular transport of Semliki Forest virus spike glycoproteins. Methods Enzymol 96, 466-485 (1983